Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carnosine | 3 | 2018 | 11 | 1.440 |
Why?
|
Risperidone | 3 | 2018 | 383 | 1.190 |
Why?
|
Disabled Persons | 4 | 2019 | 1212 | 0.940 |
Why?
|
Atrial Flutter | 2 | 2023 | 263 | 0.910 |
Why?
|
Acromegaly | 2 | 2020 | 346 | 0.730 |
Why?
|
Cause of Death | 3 | 2017 | 3584 | 0.650 |
Why?
|
Cytidine Diphosphate Choline | 1 | 2018 | 30 | 0.650 |
Why?
|
Citalopram | 2 | 2018 | 403 | 0.580 |
Why?
|
Crocus | 1 | 2016 | 7 | 0.580 |
Why?
|
Antipsychotic Agents | 3 | 2018 | 3057 | 0.550 |
Why?
|
Water Supply | 1 | 2017 | 214 | 0.550 |
Why?
|
Phytotherapy | 1 | 2016 | 298 | 0.490 |
Why?
|
Plant Extracts | 1 | 2016 | 471 | 0.440 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2020 | 2015 | 0.410 |
Why?
|
Pituitary Neoplasms | 1 | 2020 | 1345 | 0.390 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1456 | 0.390 |
Why?
|
Schizophrenic Psychology | 1 | 2018 | 1678 | 0.380 |
Why?
|
Metabolic Diseases | 1 | 2017 | 658 | 0.380 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8642 | 0.370 |
Why?
|
Schizophrenia | 2 | 2018 | 6882 | 0.340 |
Why?
|
Adenoma | 1 | 2020 | 2174 | 0.340 |
Why?
|
Occupational Diseases | 1 | 2017 | 1471 | 0.340 |
Why?
|
Sex Distribution | 3 | 2017 | 2297 | 0.310 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 2017 | 547 | 0.310 |
Why?
|
Double-Blind Method | 9 | 2018 | 12026 | 0.300 |
Why?
|
Atrial Fibrillation | 2 | 2023 | 5034 | 0.290 |
Why?
|
Diabetic Nephropathies | 3 | 2019 | 984 | 0.280 |
Why?
|
Diabetic Neuropathies | 3 | 2019 | 400 | 0.280 |
Why?
|
Health Expenditures | 1 | 2019 | 2348 | 0.280 |
Why?
|
Iran | 9 | 2018 | 708 | 0.270 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.260 |
Why?
|
Depressive Disorder, Major | 3 | 2018 | 4644 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2019 | 11725 | 0.250 |
Why?
|
Communicable Diseases | 3 | 2017 | 880 | 0.250 |
Why?
|
Quality-Adjusted Life Years | 3 | 2019 | 1683 | 0.220 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 3658 | 0.210 |
Why?
|
Drug Therapy, Combination | 5 | 2018 | 6489 | 0.210 |
Why?
|
Anxiety | 1 | 2016 | 4297 | 0.210 |
Why?
|
Age Distribution | 2 | 2017 | 2902 | 0.200 |
Why?
|
Diabetes Complications | 3 | 2017 | 1359 | 0.190 |
Why?
|
Ketamine | 2 | 2018 | 500 | 0.190 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11727 | 0.190 |
Why?
|
Life Expectancy | 2 | 2017 | 1184 | 0.190 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15165 | 0.190 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2018 | 6038 | 0.190 |
Why?
|
Male | 34 | 2023 | 350118 | 0.190 |
Why?
|
Antidepressive Agents | 3 | 2018 | 2838 | 0.190 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2020 | 46 | 0.180 |
Why?
|
Female | 36 | 2023 | 380194 | 0.180 |
Why?
|
Treatment Outcome | 14 | 2020 | 63114 | 0.180 |
Why?
|
Prepaid Health Plans | 1 | 2019 | 10 | 0.180 |
Why?
|
Public Assistance | 1 | 2019 | 47 | 0.170 |
Why?
|
Gross Domestic Product | 1 | 2019 | 77 | 0.170 |
Why?
|
Middle Aged | 24 | 2020 | 213383 | 0.160 |
Why?
|
Heart Failure | 1 | 2022 | 10900 | 0.160 |
Why?
|
Palmitic Acids | 1 | 2018 | 54 | 0.160 |
Why?
|
Endocarditis, Bacterial | 1 | 2022 | 455 | 0.160 |
Why?
|
Endocarditis | 1 | 2022 | 350 | 0.160 |
Why?
|
Child Nutrition Disorders | 1 | 2020 | 149 | 0.160 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2020 | 160 | 0.160 |
Why?
|
Pentoxifylline | 1 | 2018 | 55 | 0.160 |
Why?
|
Africa | 1 | 2020 | 673 | 0.150 |
Why?
|
Alanine Transaminase | 2 | 2019 | 592 | 0.150 |
Why?
|
Ethanolamines | 1 | 2018 | 158 | 0.150 |
Why?
|
Humans | 43 | 2023 | 744343 | 0.150 |
Why?
|
Shock, Cardiogenic | 1 | 2022 | 688 | 0.150 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2017 | 98 | 0.150 |
Why?
|
Obesity, Abdominal | 2 | 2017 | 361 | 0.140 |
Why?
|
Adult | 22 | 2020 | 214055 | 0.140 |
Why?
|
Placentation | 1 | 2016 | 82 | 0.140 |
Why?
|
Apolipoprotein A-I | 1 | 2017 | 281 | 0.140 |
Why?
|
Ankle Brachial Index | 1 | 2016 | 154 | 0.140 |
Why?
|
Diclofenac | 1 | 2016 | 71 | 0.140 |
Why?
|
Losartan | 1 | 2018 | 299 | 0.130 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2018 | 449 | 0.130 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 977 | 0.130 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2017 | 320 | 0.130 |
Why?
|
Environmental Health | 1 | 2017 | 278 | 0.130 |
Why?
|
Body Fat Distribution | 1 | 2016 | 244 | 0.130 |
Why?
|
Wounds and Injuries | 2 | 2017 | 2400 | 0.130 |
Why?
|
Models, Economic | 1 | 2019 | 713 | 0.120 |
Why?
|
Embryo Implantation | 1 | 2016 | 272 | 0.120 |
Why?
|
Postoperative Period | 1 | 2020 | 1842 | 0.120 |
Why?
|
Child, Preschool | 6 | 2020 | 41006 | 0.120 |
Why?
|
Infant | 5 | 2020 | 35136 | 0.120 |
Why?
|
Coronary Disease | 3 | 2018 | 6077 | 0.120 |
Why?
|
Infant, Newborn | 3 | 2020 | 25625 | 0.120 |
Why?
|
World Health Organization | 1 | 2020 | 1318 | 0.120 |
Why?
|
Risk Assessment | 5 | 2018 | 23338 | 0.120 |
Why?
|
Methylphenidate | 1 | 2018 | 473 | 0.120 |
Why?
|
Cholesterol, HDL | 2 | 2017 | 1814 | 0.120 |
Why?
|
Optic Nerve | 1 | 2017 | 554 | 0.120 |
Why?
|
Diabetic Retinopathy | 2 | 2019 | 1210 | 0.110 |
Why?
|
Ear Diseases | 1 | 2014 | 170 | 0.110 |
Why?
|
Vitamin D | 2 | 2016 | 3223 | 0.110 |
Why?
|
Body Mass Index | 3 | 2020 | 12720 | 0.110 |
Why?
|
Diabetic Foot | 1 | 2016 | 355 | 0.110 |
Why?
|
Premenopause | 1 | 2016 | 1033 | 0.100 |
Why?
|
Aged | 14 | 2020 | 163280 | 0.100 |
Why?
|
C-Reactive Protein | 3 | 2018 | 3778 | 0.100 |
Why?
|
Adolescent | 7 | 2018 | 85781 | 0.100 |
Why?
|
Nutritional Status | 1 | 2020 | 1609 | 0.100 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2148 | 0.100 |
Why?
|
Fibroblast Growth Factors | 1 | 2017 | 879 | 0.100 |
Why?
|
Cicatrix | 1 | 2016 | 764 | 0.100 |
Why?
|
Vitamin D Deficiency | 2 | 2016 | 1343 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.090 |
Why?
|
Central Nervous System Stimulants | 1 | 2018 | 1148 | 0.090 |
Why?
|
Child | 7 | 2018 | 77709 | 0.080 |
Why?
|
Young Adult | 5 | 2020 | 56430 | 0.080 |
Why?
|
Population Surveillance | 2 | 2017 | 2616 | 0.080 |
Why?
|
Incidence | 4 | 2022 | 20947 | 0.080 |
Why?
|
Obesity, Morbid | 2 | 2017 | 1213 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4669 | 0.080 |
Why?
|
Prevalence | 4 | 2018 | 15226 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2022 | 5317 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2017 | 1061 | 0.080 |
Why?
|
Autistic Disorder | 1 | 2017 | 1185 | 0.080 |
Why?
|
Time Factors | 2 | 2020 | 40075 | 0.080 |
Why?
|
Cesarean Section | 1 | 2016 | 1365 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2282 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4554 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2017 | 2050 | 0.080 |
Why?
|
Placenta | 1 | 2016 | 1698 | 0.070 |
Why?
|
Cross-Sectional Studies | 9 | 2019 | 25043 | 0.070 |
Why?
|
Developing Countries | 1 | 2020 | 2815 | 0.070 |
Why?
|
Depression | 2 | 2017 | 7766 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3558 | 0.070 |
Why?
|
Bariatric Surgery | 1 | 2016 | 952 | 0.070 |
Why?
|
Retina | 1 | 2017 | 2616 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1188 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 2872 | 0.060 |
Why?
|
Weight Loss | 1 | 2016 | 2622 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8324 | 0.060 |
Why?
|
Air Pollution | 1 | 2017 | 2286 | 0.060 |
Why?
|
Common Variable Immunodeficiency | 2 | 2015 | 93 | 0.060 |
Why?
|
Smoking | 1 | 2017 | 8987 | 0.050 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3508 | 0.050 |
Why?
|
Mortality | 2 | 2022 | 2864 | 0.050 |
Why?
|
Developed Countries | 1 | 2022 | 437 | 0.040 |
Why?
|
Administration, Oral | 2 | 2018 | 3913 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5751 | 0.040 |
Why?
|
Prospective Studies | 6 | 2019 | 53288 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2020 | 77449 | 0.040 |
Why?
|
Risk Factors | 7 | 2019 | 72290 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2019 | 418 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6773 | 0.040 |
Why?
|
Linear Models | 2 | 2017 | 5952 | 0.040 |
Why?
|
Morbidity | 1 | 2022 | 1769 | 0.040 |
Why?
|
Atrial Natriuretic Factor | 1 | 2018 | 393 | 0.040 |
Why?
|
Irritable Mood | 1 | 2017 | 183 | 0.040 |
Why?
|
Inflammation | 1 | 2016 | 10638 | 0.030 |
Why?
|
Consanguinity | 1 | 2017 | 454 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2019 | 21746 | 0.030 |
Why?
|
Amides | 1 | 2018 | 459 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2016 | 528 | 0.030 |
Why?
|
Genes, Recessive | 1 | 2017 | 641 | 0.030 |
Why?
|
Hyper-IgM Immunodeficiency Syndrome | 1 | 2014 | 9 | 0.030 |
Why?
|
Thiazolidinediones | 1 | 2017 | 476 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2016 | 617 | 0.030 |
Why?
|
Protein Precursors | 1 | 2018 | 1154 | 0.030 |
Why?
|
Audiometry | 1 | 2014 | 241 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2016 | 551 | 0.030 |
Why?
|
Waist Circumference | 1 | 2017 | 917 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 873 | 0.030 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2014 | 250 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 818 | 0.030 |
Why?
|
Agammaglobulinemia | 1 | 2014 | 167 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12354 | 0.030 |
Why?
|
Medical History Taking | 1 | 2016 | 783 | 0.030 |
Why?
|
Data Collection | 1 | 2022 | 3341 | 0.030 |
Why?
|
Blood Glucose | 2 | 2017 | 6256 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1179 | 0.030 |
Why?
|
Organ Size | 1 | 2017 | 2252 | 0.030 |
Why?
|
Otitis Media | 1 | 2014 | 277 | 0.030 |
Why?
|
Phenotype | 2 | 2020 | 16365 | 0.020 |
Why?
|
Prediabetic State | 1 | 2016 | 499 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21683 | 0.020 |
Why?
|
Metformin | 1 | 2017 | 835 | 0.020 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2014 | 372 | 0.020 |
Why?
|
Fasting | 1 | 2016 | 1593 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3479 | 0.020 |
Why?
|
Outpatients | 1 | 2016 | 1486 | 0.020 |
Why?
|
Ultrasonography, Prenatal | 1 | 2016 | 1695 | 0.020 |
Why?
|
Triglycerides | 1 | 2016 | 2454 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4933 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2014 | 770 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29063 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39050 | 0.020 |
Why?
|
Lipids | 1 | 2017 | 3305 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3597 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2017 | 2657 | 0.020 |
Why?
|
Mutation | 2 | 2020 | 29786 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2017 | 3864 | 0.010 |
Why?
|
United States | 2 | 2022 | 69872 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5985 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12788 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9146 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6580 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8089 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7322 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13408 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 5987 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15076 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5137 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15540 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17446 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 29144 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 40561 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 12745 | 0.010 |
Why?
|
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_